chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Covid Arm; she read an article that a Doctor wrote in which the Doctor said that the Doctor suffered similar Covid-19 arm symptoms to the patients' symptoms of Covid Arm/Injection site became a hard lump, and painful took some time to go away. she read an article that a Doctor wrote in which the Doctor said that the Doctor suffered similar Covid-19 arm symptoms to the patients' symptoms of Covid Arm/Injection site became a hard lump, and painful took some time to go away; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid Arm), VACCINATION SITE MASS (she read an article that a Doctor wrote in which the Doctor said that the Doctor suffered similar Covid-19 arm symptoms to the patients' symptoms of Covid Arm/Injection site became a hard lump, and painful took some time to go away.) and VACCINATION SITE PAIN (she read an article that a Doctor wrote in which the Doctor said that the Doctor suffered similar Covid-19 arm symptoms to the patients' symptoms of Covid Arm/Injection site became a hard lump, and painful took some time to go away) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Covid Arm), VACCINATION SITE MASS (she read an article that a Doctor wrote in which the Doctor said that the Doctor suffered similar Covid-19 arm symptoms to the patients' symptoms of Covid Arm/Injection site became a hard lump, and painful took some time to go away.) and VACCINATION SITE PAIN (she read an article that a Doctor wrote in which the Doctor said that the Doctor suffered similar Covid-19 arm symptoms to the patients' symptoms of Covid Arm/Injection site became a hard lump, and painful took some time to go away). At the time of the report, VACCINATION SITE REACTION (Covid Arm) and VACCINATION SITE MASS (she read an article that a Doctor wrote in which the Doctor said that the Doctor suffered similar Covid-19 arm symptoms to the patients' symptoms of Covid Arm/Injection site became a hard lump, and painful took some time to go away.) outcome was unknown and VACCINATION SITE PAIN (she read an article that a Doctor wrote in which the Doctor said that the Doctor suffered similar Covid-19 arm symptoms to the patients' symptoms of Covid Arm/Injection site became a hard lump, and painful took some time to go away) had resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment information was not provided.   Reporter did not allow further contact
Approximately 10-12 hours after receiving the vaccine, I developed flu like symptoms-fever, chills, nausea, muscle and joint pain.  I also developed some upper respitatory symptoms as well-stuffy nose primarily.  I went to see my family physician and they performed a flu nasal swab test, CBC, and urinalysis.  These all came back normal or negative for any disease process.  I was told to go home and take Tylenol/Ibuprofren q.6 hours and to rest.  I did so, and am feeling better this evening.
Information has been received through the Merck Pregnancy Registry through a physician concerning a female who was intramuscularly vaccinated with her first dose of GARDASIL and found out she was pregnant. No adverse events were reported. Follow up information was received from the physician who reported that the 24 year old female with a history of two previous pregnancies (1 spontaneous abortion and 1 elective termination) who on 18-OCT-2008 was vaccinated with a first dose of GARDASIL. On 21-JAN-2008 the patient underwent elective termination. Upon internal review, elective termination was determined to be an other important medical event. Additional information is not expected.
This spontaneous report was received from a licensed practical nurse and refers to a 9 weeks infant (gender not reported). There was no information about the patient's concurrent conditions, concomitant therapies or medical histories provided. On 20-SEP-2016, the patient was vaccinated with an improperly stored dose of ROTATEQ (lot # L046319, expiration date: 28-SEP-2017, dose was not reported), orally. No symptoms were reported. Administered doses of vaccines experienced the temperature excursion of 32 degrees Fahrenheit for 15 minutes and 31 degrees Fahrenheit for 15 minutes. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1608USA012794: US-009507513-1608USA012908: US-009507513-1705USA004982: US-009507513-1705USA004977: US-009507513-1705USA004978: US-009507513-1705USA004979: US-009507513-1705USA004980: US-009507513-1705USA004981: US-009507513-1705USA004894: US-009507513-1705USA004895: US-009507513-1705USA004896: US-009507513-1705USA004897: US-009507513-1705USA004898: US-009507513-1705USA004899: US-009507513-1705USA004893: US-009507513-1705USA004892: US-009507513-1705USA004891: US-009507513-1705USA004890: US-009507513-1705USA004889: US-009507513-1705USA004888: US-009507513-1705USA004887: US-009507513-1705USA004883: US-009507513-1608USA012916: US-009507513-1705USA004984: US-009507513-1705USA004985: US-009507513-1705USA004942: US-009507513-1705USA004944: US-009507513-1705USA004945: US-009507513-1705USA004947: US-009507513-1705USA004948: US-009507513-1705USA004949: US-009507513-1705USA004950: US-009507513-1705USA004951: US-009507513-1705USA004952: US-009507513-1705USA004953: US-009507513-1705USA004954: US-009507513-1705USA004955: US-009507513-1705USA004956: US-009507513-1705USA004957: US-009507513-1705USA004958: US-009507513-1705USA004959: US-009507513-1705USA004960: US-009507513-1705USA004961: US-009507513-1705USA004962: US-009507513-1705USA004963: US-009507513-1705USA004964: US-009507513-1705USA004965: US-009507513-1705USA004966: US-009507513-1705USA004967: US-009507513-1705USA004968: US-009507513-1705USA004969: US-009507513-1705USA004971: US-009507513-1705USA004972: US-009507513-1705USA004975: US-009507513-1705USA004973: US-009507513-1705USA004974: US-009507513-1705USA005007: US-009507513-1705USA005006: US-009507513-1705USA005005: US-009507513-1705USA005004: US-009507513-1705USA004943:
I came in on January 26, 2016 and received a flu shot in my left arm. I started itching that very night after taking the flu shot all over my body. My face became very red and I have not been scratching my face. 91 y/o male patient here as a walk in, c/p he got the flu shot on Feb/26/2016 and at night he developed itching. Patient has hive, and are red, has induration in left deltoid (where the shot was given) and is warm. Patient denies: fever, chills, nausea, SOB, cough, urine problems, hematic urine. Patient taking amoxicillin too. Diphenhydramine 25 mg BID, prednisone 21 dosepak.
Red circle that was warm; Red circle that was warm; Little itchy on upper (right) arm by the shoulder; Arm was sore; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Red circle that was warm), VACCINATION SITE PRURITUS (Little itchy on upper (right) arm by the shoulder), VACCINATION SITE PAIN (Arm was sore) and VACCINATION SITE ERYTHEMA (Red circle that was warm) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Little itchy on upper (right) arm by the shoulder). On 14-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Red circle that was warm) and VACCINATION SITE ERYTHEMA (Red circle that was warm). In January 2021, the patient experienced VACCINATION SITE PAIN (Arm was sore). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 15-Jan-2021, VACCINATION SITE PRURITUS (Little itchy on upper (right) arm by the shoulder) had resolved, VACCINATION SITE PAIN (Arm was sore) had resolved. At the time of the report, VACCINATION SITE WARMTH (Red circle that was warm) and VACCINATION SITE ERYTHEMA (Red circle that was warm) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment also included ice.; Sender's Comments: This case concerns a 61 Y/O F with nonserious events of unexpected vaccination site warmth, and expected vaccination site pruritus, vaccination site erythema, and vaccination site pain. Event onset on Day 11 after first dose mRNA-1273. Treated with ibuprofen and hydrocortisone cream. Events resolved or resolving. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Information has been received from a physician concerning a 23 year old female patient with no pertinent medical history who on 23-NOV-2009 was vaccinated in her left deltoid with the first dose of GARDASIL (Lot#0981Y). Concomitant therapy included LOESTRIN FE and PROZAC. The physician reported that after received GARDASIL, on 23-NOV-2009, the patient experienced discoloration at the injection site, a dent at the injection site that was about the size of a thumb and a red streak going down her arm. No lab tests were performed. At the time of the report, the physician stated that the patient had not recovered and that her experience was getting worse. Follow-up information has been received from a physician regarding a female patient with no illness at the time of vaccination, no pre-existing allergies, no birth defects, no medical conditions who on 23-NOV-2009 was intramuscularly vaccinated in her left deltoid with the first dose of GARDASIL (Lot#0981Y) at 16:24. The physician reported that on 23-NOV-2009 at 16:24 the patient experienced swelling and pain at the injection site which resolved and still had 1x1 centimeter area of erythema and indentation in her left arm. No laboratory/diagnostic tests were performed. It was reported that the patient was thin. Follow-up information has been received which reported that the reporter had not seen the patient since the last correspondence. No further information is available.
given an expired dose of Menveo / 27Apr2021 / expired in March 2021; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 18-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA268A, expiry date 31st March 2021) for prophylaxis.   On 27th April 2021, the patient received the 1st dose of Menveo. On 27th April 2021, unknown after receiving Menveo, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were provided as follows: The patient was given an expired dose of Menveo, expired on 31st March 2021, which led to expired vaccine used. No symptoms were reported. The reporter consented to follow up.
Immediately after injection hive developed at the site of injection.  Fussy.  Normal vitals.  No resp distress.  No swelling other than at injection site.  Mildly flushed but no other hives developed.  Given Benadryl with mild improvement in hive.
Vommitting,shaking, SOB, and Pt reported trouble breathing and visual problems, and throat closing.
The next am she noted hive-type rash covering all of body, no fever noted, no problems w/breathing. Seen by Dr who felt hives were related to Vaxs but no a severe rxn. DR recommended Benadryl before any more vaxs/verified by DR.
Not feeling so well; Runny noses; Doesn't have energies; Sneezes a lot; Head ache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling so well), RHINORRHOEA (Runny noses), ASTHENIA (Doesn't have energies), SNEEZING (Sneezes a lot) and HEADACHE (Head ache) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Not feeling so well), RHINORRHOEA (Runny noses), ASTHENIA (Doesn't have energies), SNEEZING (Sneezes a lot) and HEADACHE (Head ache). At the time of the report, MALAISE (Not feeling so well), RHINORRHOEA (Runny noses), ASTHENIA (Doesn't have energies), SNEEZING (Sneezes a lot) and HEADACHE (Head ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications was provided.  No treatment medications was provided.   This case was linked to MOD-2021-294340 (Patient Link).
achy and tired Narrative:  230 pm received vaccine achy, tired, headache. Reports feeling the same self care with otc nsaids on 1/21/21
itchy; severe rash hives; severe rash hives; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (itchy), URTICARIA (severe rash hives) and RASH (severe rash hives) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itchy), URTICARIA (severe rash hives) and RASH (severe rash hives). The patient was treated with PREDNISONE at an unspecified dose and frequency and LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, PRURITUS (itchy), URTICARIA (severe rash hives) and RASH (severe rash hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.
Sore arm -24 hours Extreme fatigue  8 hours Brain fog Difficulty forming words physically   Difficulty  coming up with words to use  Exhaustion
10/22/2022 sudden onset left sided hearing loss hearing loss and unsteady gait. 10/23 sudden onset of right sided hearing loss, no improvement in left hearing.  10/23 presented to ED and admitted to hospital and started on IV solumedrol with improvement in right sided hearing to near baseline by 10/24.   10/24 left sided hearing loss and unsteady gait remain.  also treating hypertensive emergency- previously not needing any medications for several years.
Approximately 3 to 4 hours after injection, significant pain set in left arm.  By approximately 6 to 8 hours after injection the left arm, the area from shoulder to elbow was in severe pain and the left shoulder was virtually immobilized.  The [left] arm could not be raised or moved in any direction.  By 24 hours after injection, there was virtually no improvement, pain and immobility remained.  By 48 hours after injection, the pain in [left] arm continues but was beginning to somewhat subside.  Mobility was still very limited but slightly increased as compared to the prior day.  Shoulder movement is painful and also very sensitive (painful) to touch.  There was no pain or restriction of movement in this shoulder prior to injection.  As of this writing, symptoms appear to slowly improving but have not completely subsided.
Nausea for 4 days to this point, individual "is never nauseous" and has been since the vaccine; This is a spontaneous report from a contactable consumer. A 75-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 02Feb2021 at single dose for COVID-19 immunisation. Medical history included thyroid imbalance, high blood pressure. The patient had no known allergies. No other vaccine was received in four weeks. No COVID prior vaccination. The patient's concomitant medications were not reported. The patient experienced nausea for 4 days to this point, she "is never nauseous" and had been since the vaccine on 02Feb2021. No treatment was received for event. No COVID tested post vaccination. The outcome of event was not recovered.  Information on lot/batch has been requested.
2 days after her first shot, woke up with sudden onset, acute edema of her right hand and right arm, not associated with any trauma or injury to that extremity.  Her edema has continued since then.  One day after her second dose of Pfizer vaccine (lot # EN6201) on 2/20, which she received in her left arm, she developed sudden acute edema in her right foot and leg.  She was seen on 2/22 by a nurse practitioner and had ultrasounds of her right arm and right leg.  The ultrasounds ruled out  DVTs  and/or vascular abnormalities.  Her physician concluded that her edema is an adverse effect of the Pfizer vaccine.
This spontaneous report as received from a consumer (patient's mother) refers to a 13 year old female patient. The patient had no pertinent medical history, drug reactions/allergies and concomitant medication. On an unknown date in August 2017, the patient was vaccinated with first dose of GARDASIL 9 and on 10-APR-2018, the patient was vaccinated with second dose of GARDASIL 9 intramuscularly for prevention of human papillomavirus (HPV) (dose, frequency, lot # and expiry date were not reported). On 15-APR-2018 (reported as approximately 5 days after receipt of second dose), the patient began to break out in red, itchy, welts all over the body from head to toe. The patient's mother also stated that that patient had not been exposed to any new environmental changes or potential skin irritants and the reaction began while the patient was sleeping in her bed. The patient was administered with BENEDRYL to counteract the reaction, which was initially successful, however, after the effects of the BENEDRYL wore off, the reaction began to spread again. The patient was also prescribed with ZANTAC (dose unspecified) and prednisone (manufacturer unknown) 60 mg in addition to BENEDRYL once every 6 hours by the pediatrician. The patient had responded well to BENEDRYL, prednisone (manufacturer unknown) and ZANTAC regimen and was able to attend the school. The patient's mother closely monitored the patient for rebound signs of breaking out again. The patient's mother explained that the patient was not expected to need any future dosing with the GARDASIL 9 as she had followed the 2 dose series for the vaccine. It was reported that, the patient sought medical attention for the events. The outcome of pruritus, erythema and urticaria was reported as recovering/resolving. The relationship between the events and GARDASIL 9 was not provided.
Information has been received from a physician concerning a 14 year old female patient who on an unknown date was vaccinated with the first dose of GARDASIL (lot # not reported). On an unspecified date, the patient developed a pancreatic mass after receiving the GARDASIL. The patient was hospitalized and discharged on unknown dates. At the time of the report, the patient had not recovered. Additional information has been requested.
Large erythema and bruising noted to Left thigh. Patient states it is not painful, but very itchy. Swelling has started to go down. Treatment includes:  Benadryl liquid 10 ml twice a day for next few days   Topical triamcinolone cream twice a day for up to 7 days (until clear)    Cool pack or heat pack (would like to try warm with the bruising under rash area)    Ibuprofen as needed for pain
Covid19 breakthrough.  Vaccinated on 03/13/2021.  38 y/o PMH sleep apnea presents to ED with c/o palpitations, low back pain, fever, chills, congestion and generalized frontal HA x1 day.  Room air sat 97%, CXR no acute process, CTA Chest no pulm emboli.  Pt started on oral steroids.
Itching, throat and tongue and throat tingling, nauseous. No shortness of breath BENADRYL 50 mg taken. At time of completing this form, 10:45 am, she is still itching with tongue and throat tingling.
swollen lymph node a couple of days later/swollen lymph node a couple of days later. Which is still a little swollen but improving; pain at injection site/painfulness at the injection site; shoulder became very red/painfulness at injection site and redness/ was a defined red mark where the injections was; This is a spontaneous report from a contactable nurse. A 33-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EK9231, expiry date: 30Apr2021), via an unspecified route of administration on 29Dec2020 at single dose for COVID-19 immunization. Medical history included immunosuppression. Concomitant medication included ongoing vedolizumab (ENTYVIO) for immunosuppresion. The patient got a couple of the side effects listed. She developed painfulness at the injection site, and it was red a couple of days. She is wondering if she needs to be worried about getting the second one. It was pretty painful that night. It was pretty painful for the next day. If someone barely brushed up against it, it was very painful. Two days later, her husband noticed her shoulder was very red. And then she realized there was a defined red mark where the injections was. The pain is fine now. She didn't get a rash or have trouble breathing. She did have a swollen lymph node a couple of days later. Which is still a little swollen but improving. She does take an immunosuppressant. The outcome of the events pain at injection site and shoulder became very red/painfulness at injection site and redness/ was a defined red mark where the injections was recovered, while recovering for the event swollen lymph node a couple of days later was recovering.
1 week following administration developed swelling to size of grapefruit, induration, redness with blanching, and itchiness
patient reported feeling nauseous and dizzy about 15 minutes post vaccination. Was brought to exam room to lay down, was given some apple juice to drink. Vital signs were checked, patient remained onsite for about 1 hour being monitored. Stated she felt better but was still nauseous when she was released to her husband to drive her home. No history of vaccine reaction in the past
Syncopal, presyncopal syndrome, low BP day following vaccine. Got vaccine in afternoon, woke up at 3:00 with HA, fever and sx above.
This spontaneous report as received from a medical assistant (M.A.) refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 30-JUN-2015, the patient was vaccinated with the third dose of improperly stored oral, ROTATEQ (lot # L000571, expiration date 26-JUL-2016) (dose unspecified). No concomitant medications were reported. No adverse effects have been reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Following day: fatigue, HA, that evening mother reported patient had wet bed. Positive lethargy. Local reaction: arm swelling x one month.
Patient began feeling ?offs? and then from Monday through Friday he could not keep any food down. No other symptoms other than nausea and vomiting. He went from  191 to 176 in 6 days.
hardening and swelling of areas where she had hyalurinoc acid fillers. It lasted for 1 day until she took Benadryl.
Red face rash morning of 2 days following vaccine Dull headache, day of vaccine